| 英文名称 | 中文名称 | CAS | MF |
|
VAV3-D2 Fusion Protein (SH3)
|
|
|
|
|
VCAM-1 PRIMER PAIR
|
|
|
|
|
VAV2-D1 Fusion Protein (SH3)
|
|
|
|
|
VAV2-D2 Fusion Protein (SH3)
|
|
|
|
|
VAV1-D2 Fusion Protein (SH3)
|
|
|
|
|
VAV3- D1 Fusion Protein (SH3)
|
|
|
|
|
VCAM-1 (Soluble) EIA(2 X 96)
|
|
|
|
|
VCAM-1 (Soluble) EIA
|
|
|
|
|
VCAM-1(Vascuolar cell adhesion molecule 1)CD106
|
血管内皮细胞粘附分子
|
|
|
|
Vat Yellow 10
|
还原黄 10
|
2379-76-2
|
C68H42N6O8
|
|
Vat Yellow 33
|
还原黄 33
|
12227-50-8
|
C54H32N4O6
|
|
Vat Yellow Brown G
|
还原黄棕G
|
|
|
|
Vat Yellow 21
|
|
1328-40-1
|
|
|
Vat Yellow 31
|
|
6871-93-8
|
C22H11Cl2N3O2
|
|
Vat Yellow 11
|
|
|
|
|
Vat Yellow 3
|
|
|
|
|
VATYELLOW G
|
|
|
|
|
Vat yellow 49
|
|
57455-83-1
|
|
|
VATYELLOW26
|
|
|
|
|
Vat Yellow 2
|
还原黄 2
|
129-09-9
|
C28H14N2O2S2
|
|
Vat Yellow 12 (C.I.)
|
还原黄12
|
6370-75-8
|
C44H26N4O8
|
|
Vat Yellow 4
|
还原黄4
|
128-66-5
|
C24H12O2
|
|
2 VAT YELLOW2
|
还原黄
|
|
|
|
Vat Yellow 28
|
|
4229-15-6
|
C28H13NO4
|
|
Vat Yellow 3GF
|
|
|
|
|
Vat Yellow GCN Paste
|
|
|
|
|
Vat Yellow 6GD
|
|
|
|
|
Vat Yellow FG
|
|
|
|
|
Vat Yellow F3GL
|
|
|
|
|
Vat Yellow 4GF
|
|
|
|
|
Vat Yellow 46
|
还原黄 46
|
12237-50-2
|
|
|
Vat Yellow 7GK
|
|
|
|
|
Vav1-D2, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav1-D1, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav3-D2, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav2-D1, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav2-D2, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav3-D1, Recombinant, Human (VAV Proto-oncogene)
|
|
|
|
|
Vav (GDP/GTP Exchange Factor)
|
|
|
|
|
Vav (GDP, GTP Exchange Factor) A
|
|
|
|
|
Vav2 (GDP, GTP Exchange Factor 2)
|
|
|
|
|
VAU regimen
|
|
|
|
|
VCAT ANTIBIOTIC SUPPLEMENT
|
|
|
|
|
VA/VINYL BUTYL BENZOATE/CROTONATES COPOLYMER
|
VA/丁基苯甲酸乙烯酯/巴豆酸(酯)类共聚物
|
|
|
|
V-CATH protein
|
|
|
|
|
VBMC
|
|
|
|
|
VCAV protocol
|
|
|
|
|
VBMC inter.for 7AVC,Cefixime cefdinir
|
|
|
|
|
Vav1 (phospho Y160)
|
|
|
|
|
Vav3, phosphorylated (Tyr173) (GDP/GTP Exchange Factor)
|
|
|
|
|
Vav1, phosphorylated (Tyr160) (GDP/GTP Exchange Factor)
|
|
|
|
|
VBMF protocol
|
|
|
|
|
VAV2 protein
|
|
|
|
|
VAV protocol
|
|
|
|
|
V-c coated
|
|
|
|
|
Vb1(Mononitrate&Hcl)
|
|
|
|
|
VCCP protocol
|
|
|
|
|
VBM protocol 2
|
|
|
|
|
VBM protocol
|
|
|
|
|
VCDP protocol
|
|
|
|
|
Vax1 protein
|
|
|
|
|
Vax protein
|
|
|
|
|
VCD protocol
|
|
|
|
|
Vax2 protein
|
|
|
|
|
Vaxstrate
|
|
|
|
|
VaxSyn HIV-1 (gp160) vaccine
|
|
|
|
|
VAZO 44
|
VAZO44
|
|
|
|
VAZO 56 & 68
|
|
|
|
|
VAZO 52
|
偶氮脒类引发剂V65
|
|
|
|
VAZO 50
|
|
|
|
|
VAZO 88
|
|
|
|
|
VAZO 76
|
|
|
|
|
VAZO 64(AIBN)
|
|
|
|
|
VAZO 56 WSP
|
|
|
|
|
VAZO 44WSP
|
|
|
|
|
VAZO WSP 56
|
|
|
|
|
VAZO 56 WSW
|
|
|
|
|
VAZO 68WSP
|
|
|
|
|
VBP1 protein
|
|
|
|
|
VCH-916
|
VCH-916
|
1200133-34-1
|
C26H36KNO4S
|
|
VCH-040
|
VCH-040
|
895133-94-5
|
C20H16FN3O4
|
|
VCH-759
|
VCH-759
|
713139-25-4
|
C25H31NO4S
|
|
VbrA protein
|
|
|
|
|
Vb6(PyridoxineHcl)
|
|
|
|
|
VD 99-11
|
|
|
|
|
VD2
|
维生素D2
|
|
|
|
VD3
|
VD3
|
|
|
|
vBRIDP
|
VBRIDP
|
384842-25-5
|
C23H31P
|
|
v[4-(6-Chloro-2-Methylsulfanyl-pyriMidin-4-ylaMino)-cyclohexyl]-carbaMic acid tert-butyl ester
|
|
|
C16H25ClN4O2S
|
|
VCI Gasify antirust antistatic packaging material
|
VCI气化防锈防静电包装材料
|
|
|
|
VCH protocol
|
|
|
|
|
Vb12 sulphate
|
|
|
|
|
VDAC1, Control Peptide (Voltage-Dependent Anion Channel 1, Mitochondrial Porin)
|
|
|
|
|
VDBCP protocol
|
|
|
|
|
VDA-P protocol
|
|
|
|
|
VCMA protocol
|
|
|
|
|
VBVP protocol
|
|
|
|
|
VD3-D6
|
维生素 D3-D6
|
118584-54-6
|
C27H38D6O
|
|
VD3 crystall,Cholecalciferol
|
维生素D3结晶
|
|
C27H44O
|
|
VDE endonuclease
|
|
|
|